IDENTIFICATION OF SUSCEPTIBILITY GENES FOR NIDDM
NIDDM 易感基因的鉴定
基本信息
- 批准号:2905597
- 负责人:
- 金额:$ 33.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-02-27 至 2001-06-30
- 项目状态:已结题
- 来源:
- 关键词:Epstein Barr virus calcium channel cell line clinical research diabetes mellitus genetics family genetics genetic markers glucokinase glucose metabolism glycogen synthase glycoproteins hexokinase hormone regulation /control mechanism human subject insulin insulin receptor linkage mapping molecular cloning muscle cells noninsulin dependent diabetes mellitus pancreatic islets tumor necrosis factor alpha voltage gated channel
项目摘要
DESCRIPTION: (Adapted from the Investigator's Abstract) Genetic
susceptibility plays a major role in the development of non-insulin
dependent diabetes mellitus (NIDDM). Involvement of several genes
appears likely, and their identification has become feasible with
recently developed methods of molecular genetics. Using a large panel of
informative families, this proposal aims to find susceptibility genes for
NIDDM using the candidate gene approach. The investigators will examine
a series of known candidate genes which encode for proteins involved in
glucose disposal in muscles as well as newly identified genes which are
over- or under-expressed in muscles of NIDDM patients. The specific aims
of this research proposal are to 1) Recruit and examine 90 informative
families with NIDDM that have been selected to maximize power to detect
susceptibility genes for NIDDM; 2) Establish EBV transformed lymphoblast
cell lines for the examined family members (1200 individuals) and prepare
DNA for genetic studies; 3) Genotype these members of the NIDDM families
with highly informative DNA markers at four groups of candidate gene
loci: I) Genes involved in glucose disposal and insulin action pathway
such as: hexokinase II, glycogen synthase, insulin receptor, insulin
receptor substrate-2; ii) Genes which are over- or under-expressed in
muscle of patients with NIDDM such as rad and 5-10 others identified by
subtraction cloning; iii) Genes known to inhibit insulin stimulated
glucose uptake such as: membrane glycoprotein PC-1 and TNF-alpha; iv)
Gene involved in glucose signaling in beta-cells such as: glucokinase and
the alpha-1 subunit of the voltage-dependent calcium channels. 4)
Determine linkage between NIDDM and the examined candidate genes using
non-parametric and likelihood based methods.
These investigators have obtained preliminary results which suggest that
allelic variation at the rad locus contributes to the development of
NIDDM in a significant subset of families. If the results are confirmed
in a larger group of families, rad will be the first gene linked with the
development of NIDDM. These findings will provide the bases for
investigations of specific molecular defects which underlie
susceptibility to NIDDM.
描述:(改编自《调查者摘要》)基因
易感性在非胰岛素的发生发展中起主要作用
依赖型糖尿病(NIDDM)。几个基因的参与
看起来很有可能,而且他们的身份识别已经变得可行
最近发展起来的分子遗传学方法。使用一大块面板
信息丰富的家庭,这项建议的目的是寻找
使用候选基因方法的NIDDM。调查人员将检查
一系列已知的候选基因,它们编码参与
肌肉中葡萄糖的处理以及新发现的基因
在NIDDM患者肌肉中高表达或低表达。具体目标
这项研究建议的是1)招聘和审查90名信息量大的
被选为最大限度提高检测能力的NIDDM患者家庭
NIDDM的易感基因;2)建立EBV转化的淋巴母细胞
为被检查的家庭成员(1200人)建立细胞系并准备
用于遗传学研究的DNA;3)NIDDM家族成员的基因分型
在四组候选基因上具有高度信息量的DNA标记
基因座:I)参与葡萄糖代谢和胰岛素作用途径的基因
如:己糖激酶II、糖原合成酶、胰岛素受体、胰岛素
受体底物-2;ii)中过度或低表达的基因
如RAD等NIDDM患者的肌肉和其他5-10名由
消减克隆;iii)已知的抑制胰岛素刺激的基因
葡萄糖摄取,如膜糖蛋白PC-1和肿瘤坏死因子-α;iv)
β细胞中参与葡萄糖信号转导的基因,如:葡萄糖激酶和
电压依赖性钙通道的α-1亚基。4)
确定NIDDM与所检查的候选基因之间的连锁
非参数和基于似然的方法。
这些调查人员已经获得了初步结果,表明
RAD基因座上的等位基因变异有助于遗传病的发生。
NIDDM在一个重要的家庭子集。如果结果得到确认
在一个更大的家庭群体中,rad将是第一个与
NIDDM的发展。这些发现将为以下研究提供依据
特定分子缺陷的研究
对NIDDM的易感性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrzej S Krolewski其他文献
Andrzej S Krolewski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrzej S Krolewski', 18)}}的其他基金
Causal connections between axon guidance proteins and early progressive kidney function decline in diabetes
轴突引导蛋白与糖尿病早期进行性肾功能衰退之间的因果关系
- 批准号:
10598448 - 财政年份:2022
- 资助金额:
$ 33.81万 - 项目类别:
Causal connections between axon guidance proteins and early progressive kidney function decline in diabetes
轴突引导蛋白与糖尿病早期进行性肾功能衰退之间的因果关系
- 批准号:
10343592 - 财政年份:2022
- 资助金额:
$ 33.81万 - 项目类别:
Development of Prognostic Algorithms to Identify Subjects at High Risk of ESKD in Type 2 Diabetes
开发预后算法来识别 2 型糖尿病 ESKD 高风险受试者
- 批准号:
10693928 - 财政年份:2021
- 资助金额:
$ 33.81万 - 项目类别:
Development of Prognostic Algorithms to Identify Subjects at High Risk of ESKD in Type 2 Diabetes
开发预后算法来识别 2 型糖尿病 ESKD 高风险受试者
- 批准号:
10491130 - 财政年份:2021
- 资助金额:
$ 33.81万 - 项目类别:
Development of Prognostic Algorithms to Identify Subjects at High Risk of ESKD in Type 2 Diabetes
开发预后算法来识别 2 型糖尿病 ESKD 高风险受试者
- 批准号:
10364853 - 财政年份:2021
- 资助金额:
$ 33.81万 - 项目类别:
Mapping Genes for End-Stage Renal Disease in Type 1 Diabetes
绘制 1 型糖尿病终末期肾病基因图谱
- 批准号:
7290994 - 财政年份:2006
- 资助金额:
$ 33.81万 - 项目类别:
Mapping Genes for End-Stage Renal Disease in Type 1 Diabetes
绘制 1 型糖尿病终末期肾病基因图谱
- 批准号:
7224532 - 财政年份:2006
- 资助金额:
$ 33.81万 - 项目类别:
The Urinary Proteome and Renal Function Loss in Diabetes
糖尿病患者的尿蛋白质组和肾功能丧失
- 批准号:
7095245 - 财政年份:2004
- 资助金额:
$ 33.81万 - 项目类别:
The Urinary Proteome and Renal Function Loss in Diabetes
糖尿病患者的尿蛋白质组和肾功能丧失
- 批准号:
7470644 - 财政年份:2004
- 资助金额:
$ 33.81万 - 项目类别:
The Urinary Proteome and Renal Function Loss in Diabetes
糖尿病患者的尿蛋白质组和肾功能丧失
- 批准号:
7257250 - 财政年份:2004
- 资助金额:
$ 33.81万 - 项目类别:
相似海外基金
L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
- 批准号:
10668210 - 财政年份:2023
- 资助金额:
$ 33.81万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
- 批准号:
10603554 - 财政年份:2023
- 资助金额:
$ 33.81万 - 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
- 批准号:
10684558 - 财政年份:2023
- 资助金额:
$ 33.81万 - 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
- 批准号:
10815882 - 财政年份:2023
- 资助金额:
$ 33.81万 - 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
- 批准号:
10628914 - 财政年份:2023
- 资助金额:
$ 33.81万 - 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
- 批准号:
10734121 - 财政年份:2023
- 资助金额:
$ 33.81万 - 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
- 批准号:
10628911 - 财政年份:2023
- 资助金额:
$ 33.81万 - 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
- 批准号:
2200474 - 财政年份:2022
- 资助金额:
$ 33.81万 - 项目类别:
Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
- 批准号:
452107 - 财政年份:2021
- 资助金额:
$ 33.81万 - 项目类别:
Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
- 批准号:
10399417 - 财政年份:2021
- 资助金额:
$ 33.81万 - 项目类别: